论文部分内容阅读
生物医药的中小企业都有研发周期长、投入大、风险高的共性问题。一般来说,新药研发的周期长达10年,需要巨额的研发费用。
Biomedical SMEs have a long R & D cycle, investment, high risk of common problems. In general, drug development cycle of up to 10 years, requires huge R & D costs.